The effects of cannabinoids on the pharmacokinetics of indinavir and nelfinavir

AIDS

Volumn 16, Issue 4, 2002, Pages 543-550

  Kosel, Bradley W ^a   Aweeka, Francesca T ^a   Benowitz, Neal L ^a   Shade, Starley B ^a   Hilton, Joan F ^a   Lizak, Patricia S ^a   Abrams, Donald I ^a  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

Cannabinoids; HIV; HIV protease inhibitors; Indinavir; Interaction; Nelfinavir; Pharmacokinetics

Indexed keywords

CANNABINOID; DRONABINOL; INDINAVIR; NELFINAVIR;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INTERACTION; DRUG METABOLISM; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; VIRUS LOAD;

ADULT; APPETITE STIMULANTS; DRUG INTERACTIONS; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; INDINAVIR; MALE; MARIJUANA SMOKING; MIDDLE AGED; NELFINAVIR; TETRAHYDROCANNABINOL;

EID: 0037040369     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200203080-00005     Document Type: Article

References (27)

1. Short term safety of cannabinoids in HIV patients
2. Marijuana as antiemetic medicine: A survey of oncologists' experiences and attitudes
3. Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection
4. Selective inactivation of mouse liver cytochrome P-450IIIA by cannabidiol
5. Recent advances in the metabolism of cannabinoids
6. Inhibition of cyclosporine and tetrahydrocannabinol metabolism by cannabidiol in mouse and human microsomes
7. Effects of delta-9-tetrahydrocannabinol on drug distribution and metabolism. Antipyrine, pentobarbital, and ethanol
8. Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana
9. An LC-MS-MS method for the determination of indinavir, an HIV-1 protease inhibitor, in human plasma
10. Quantitative measurement of delta 9-tetrahydrocannabinol and two major metabolites in physiological specimens using capillary column gas chromatography negative ion chemical ionization mass spectrometry
11. The lack of association of marijuana and other recreational drugs with progression to AIDS in the San Francisco Men's Health study
12. Life-threatening interactions between HIV-1 protease inhibitors and the illicit drugs MDMA and gamma-hydroxybutyrate
13. Fatal interaction between ritonavir and MDMA
14. Medicinal marijuana: A comprehensive review
15. Indinavir concentrations and antiviral effect
16. Virologic response-plasma drug concentration relationship in phase III study of nelfinavir mesylate
17. Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients
18. Low plasma concentrations of indinavir are related to virological treatment failure in HIV-1-infected patients on indinavir-containing triple therapy
19. Indinavir (IDV) maximum plasma concentration (Cmax) predicts CD4+ response in persons with highly suppressed HIV RNA
20. Human hepatic microsomal metabolism of delta 1-tetrahydrocannabinol
21. Characterization of cannabidiol-mediated cytochrome P450 inactivation
22. Characterization of cytochrome P450 3A inactivation by cannabidiol: Possible involvement of cannabidiol-hydroxyquinone as a P450 inactivator
23. Induction and genetic regulation of mouse hepatic cytochrome P450 by cannabidiol
24. Forgotten target for marijuana: The endocannabinoid system in the gut
25. Marijuana in the new millennium: Perspectives for cannabinoid research
26. Circulating metabolites of the human immunodeficiency virus protease inhibitor nelfinavir in humans: Structural identification, levels in plasma, and antiviral activities
27. Drug interactions with tobacco smoking. An update